The latest London South East Webinar takes place on July 6. Come and hear CEO’s from Orosur Mining, Caledonia Mining, Glantus Holdings and Tekcapital speak. Please register here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmunodiagnostic Systems Share News (IDH)

Share Price Information for Immunodiagnostic Systems (IDH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 378.00
Bid: 376.00
Ask: 380.00
Change: 0.00 (0.00%)
Spread: 4.00 (1.06%)
Open: 378.00
High: 378.00
Low: 376.00
Yest. Close: 378.00
IDH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UK WINNERS & LOSERS SUMMARY: Immunodiagnostic Up On Covid Kit Rollout

Fri, 27th Nov 2020 10:49

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.



FTSE 100 - WINNERS



Diageo, up 0.7%. Morgan Stanley upgraded the distiller to Overweight from Equal Weight.



FTSE 100 - LOSERS



Homeserve, down 3.5%. The home emergency cover provider finds itself on the brink of automatic demotion from the large-cap index ahead of the FTSE Russell index review changes next week. Homeserve currently ranks 115th in the FTSE 350 by market capitalisation, just below the safety threshold at 110th place, with a total market value of GBP3.4 billion.



FTSE 250 - LOSERS



JD Wetherspoon, down 3.0%. The pub chain complained bitterly about the UK government's post-lockdown tier system, which effectively forces almost half of its about 870 pubs to close. Just 13 Wetherspoon pubs in England are in areas classified as Tier 1, under the new UK virus restrictions that go into place from next week. In addition, there are 51 pubs in Wales, where the regulations equate to Tier 1 in England. For Wetherspoon, Tier 2 affects 435 pubs. This tier includes 17 pubs in Scotland where the regulations approximate to Tier 2 in England, the pub chain said. Wetherspoon highlighted that it has 366 pubs which will remain closed. Of these, 315 are in Tier 3 in England and 51 are in Northern Ireland and Scotland. These 51 pubs have similar restrictions to Tier 3 in England.



Virgin Money UK, down 2.5%. Citigroup downgraded the challenger bank to Neutral from Buy. Earlier this week, the lender reported a jump in credit impairment charges, which it said reflected a "cautious approach to an uncertain economic environment".



OTHER MAIN MARKET AND AIM - WINNERS



Immunodiagnostic Systems Holdings, up 25%. The diagnostic solutions provider announced that two rapid Covid-19 test kits are now available for sale in the UK and Europe, provided by the company's partners. The two tests provide a result within 15 minutes and will be available in CE mark-accepting countries. Immunodiagnostic Systems said the SARS-CoV-2 antigen rapid test kits can be performed by a trained healthcare professional in community locations, such as workplaces and schools. The company did not name its partners for the tests. The two tests, one using a cassette format and the other a test card format, have a sensitivity of 97% and 92%, respectively.



Reach, up 1.5%. The newspaper, magazine and digital publisher said revenue has seen a decline towards the close of its financial year but boasted of a growing online business, giving the company confidence going forward. For the five months to November 22, revenue fell 14% year-on-year with print revenue driving the decline, having fallen 20% itself. Reach however said it saw strong digital revenue growth of 16, and it claimed increased customer engagement. "Circulation sales have remained resilient despite the recent lockdowns, supported by management action on availability and increased cross-promotion of national and regional titles," Reach said. The media firm added that it expects these trends continue into December, although noted that it is difficult to make any forecasts due to the macroeconomic uncertainties. Reach has "significantly" reduced costs as part of a new, more efficient operating model.



OTHER MAIN MARKET AND AIM - LOSERS



Walker Crips Group, down 4.5%. The stockbroker posted a swing to loss for the first half of financial 2021 as revenue declined due to the pandemic but noted a recent improvement in its performance. For the six months ended September 30, Walker Crips posted pretax loss of GBP374,000, winging from a profit of GBP617,000 the year prior. This was a revenue declined 7.7% year-on-year to GBP14.4 million from GBP15.6 million as financial markets fell as a result of the pandemic. Assets under management and administration as at September 30 was GBP4.8 billion, down from GBP5.1 billion at the same time last year. An interim dividend of 0.15p was declared, a 75% reduction from 0.60p paid the year prior.



By Arvind Bhunjun; arvindbhhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

AIM WINNERS & LOSERS: Immunodiagnostic surges on PerkinElmer takeover

AIM WINNERS & LOSERS: Immunodiagnostic surges on PerkinElmer takeover

17 May 21 11:15

Immunodiagnostic Systems agrees GBP110 million bid by US's PerkinElmer

Immunodiagnostic Systems agrees GBP110 million bid by US's PerkinElmer

17 May 21 09:21

LONDON BRIEFING: Ryanair hopeful for end of curbs, "gamechanger" jet

LONDON BRIEFING: Ryanair hopeful for end of curbs, "gamechanger" jet

17 May 21 08:13

LONDON MARKET PRE-OPEN: Vistry raises profit guidance on strong demand

LONDON MARKET PRE-OPEN: Vistry raises profit guidance on strong demand

17 May 21 07:52

AIM WINNERS & LOSERS: InfraStrata jumps on joint contract win

AIM WINNERS & LOSERS: InfraStrata jumps on joint contract win

16 Apr 21 11:33

TRADING UPDATES: AFC raises GBP36 million; Angle wins service contract

TRADING UPDATES: AFC raises GBP36 million; Angle wins service contract

16 Apr 21 11:28

Immunodiagnostic Systems recovers 'strongly' in H2

(Sharecast News) - Diagnostic testing kits producer Immunodiagnostic Systems said on Friday that trading had "recovered strongly" in the second half of the year, bouncing back from adverse impacts stemming from the Covid-19 pandemic seen in the first half.

16 Apr 21 07:37

Immunodiagnostic Systems gets emergency FDA approval for Covid-19 test

(Sharecast News) - Clinical laboratory diagnostic technology company Immunodiagnostic Systems (IDS) has reached an agreement with its partner Technogenetics (TGS), it announced on Monday, under which TGS would supply it with a fully-automated SARS-CoV-2 IgG test, to run on its 'IDS-iSYS' analyser, for sales in the United States.

29 Mar 21 12:24

Immunodiagnostic gets US emergency green light for Covid-19 virus test

Immunodiagnostic gets US emergency green light for Covid-19 virus test

29 Mar 21 09:17

Immunodiagnostic Systems launces two rapid Covid-19 tests

(Sharecast News) - Clinical laboratory diagnostics company Immunodiagnostic Systems announced on Friday that two SARS-CoV-2 antigen rapid test kits for Covid-19 were now available for sale in the UK, the European Union, and other countries which accept the CE-mark as the basis of regulatory approval.

27 Nov 20 11:59

UK WINNERS & LOSERS SUMMARY: Immunodiagnostic Up On Covid Kit Rollout

UK WINNERS & LOSERS SUMMARY: Immunodiagnostic Up On Covid Kit Rollout

27 Nov 20 10:49

Immunodiagnostic Systems Notes Rollout Of Covid-19 Rapid Test Kits

Immunodiagnostic Systems Notes Rollout Of Covid-19 Rapid Test Kits

27 Nov 20 10:33

IN BRIEF: Immunodiagnostic Systems Interim Loss Widens On Revenue Drop

IN BRIEF: Immunodiagnostic Systems Interim Loss Widens On Revenue Drop

20 Nov 20 19:25

UK EXECUTIVE CHANGE SUMMARY: InnovaDerma Hires Blake Hughes As New CEO

UK EXECUTIVE CHANGE SUMMARY: InnovaDerma Hires Blake Hughes As New CEO

18 Nov 20 15:42

IN BRIEF: Immunodiagnostic Systems Interim Revenue Falls By 21%

IN BRIEF: Immunodiagnostic Systems Interim Revenue Falls By 21%

23 Oct 20 17:37

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.